Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azeet Narayan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|July 21, 2018
Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase InhibitorsCecilia Lopez Sambrooks, Marta Baro, Amanda Quijano, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
MEDUSA: Maintaining Entire DNA Duplexes for Utmost Sequencing AccuracyKan Xiong, Rachel Li, Ning Li, et al.
Archives of Microbiology|December 4, 2008
Comparative genomic study of spo0E family genes and elucidation of the role of Spo0E in Bacillus anthracisGyanendra P Dubey, Azeet Narayan, Abid R Mattoo, et al.
JCO Precision Oncology|February 27, 2024
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid TumorsYiduo Hu, Azeet Narayan, Yunshan Xu, et al.
Plos One|November 11, 2009
Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growthKrishan Kumar, Megha Tharad, Swetha Ganapathy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNASarah B Goldberg, Azeet Narayan, Adam J Kole, et al.
Cancer|February 7, 2025
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trialMichael Cecchini, Mary Jo Pilat, Nataliya Uboha, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Benchmarking of duplex sequencing approaches to reveal somatic mutation landscapesYang Zhang, Vinayak V Viswanadham, Michail Andreopoulos, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Comprehensive benchmarking of somatic single-nucleotide variant and indel detection at ultra-low allele fractions using short- and long-read dataYoo-Jin Jiny Ha, Dominika Maziec, Julia Markowski, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|July 21, 2018
Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase InhibitorsCecilia Lopez Sambrooks, Marta Baro, Amanda Quijano, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
MEDUSA: Maintaining Entire DNA Duplexes for Utmost Sequencing AccuracyKan Xiong, Rachel Li, Ning Li, et al.
Archives of Microbiology|December 4, 2008
Comparative genomic study of spo0E family genes and elucidation of the role of Spo0E in Bacillus anthracisGyanendra P Dubey, Azeet Narayan, Abid R Mattoo, et al.
JCO Precision Oncology|February 27, 2024
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid TumorsYiduo Hu, Azeet Narayan, Yunshan Xu, et al.
Plos One|November 11, 2009
Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growthKrishan Kumar, Megha Tharad, Swetha Ganapathy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNASarah B Goldberg, Azeet Narayan, Adam J Kole, et al.
Cancer|February 7, 2025
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trialMichael Cecchini, Mary Jo Pilat, Nataliya Uboha, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Benchmarking of duplex sequencing approaches to reveal somatic mutation landscapesYang Zhang, Vinayak V Viswanadham, Michail Andreopoulos, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Comprehensive benchmarking of somatic single-nucleotide variant and indel detection at ultra-low allele fractions using short- and long-read dataYoo-Jin Jiny Ha, Dominika Maziec, Julia Markowski, et al.
Pageof 2